Is VRDN stock safe? | Glauxie AI

Q: Is VRDN stock safe?

Viridian Therapeutics, Inc. (VRDN) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Stephen F. Mahoney. Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in... Employees: 252.

Q: What are the risks of investing in VRDN?

Identify key risks of investing in VRDN — debt, competition, volatility, and sector headwinds.

Q: Is VRDN a good long-term investment?

Evaluate VRDN as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does VRDN have?

Review VRDN total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is VRDN stock safe?

🦉

Viridian Therapeutics, Inc. (VRDN)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOStephen F. Mahoney

Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody,...

Key Executives

Name	Title
Anthony Casciano	Chief Commercial Officer
Eric N. Olson	Co-Founder & Chairman of Scientific Advisory Board
Jennifer Tousignant	Chief Legal Officer & Corporate Secretary
Marvin H. Caruthers	Co-Founder & Scientific Advisory Board Member
Melissa Manno	Chief Human Resources Officer
Michael R. Bristow	Co-Founder & Member of the Scientific Advisory Board

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

VRDN Profile Financials

What are the risks of investing in VRDN? Is VRDN a good long-term investment? How much debt does VRDN have?